Last reviewed · How we verify

NCT03109613

PEEP and V/Q Mismatch in Premature Infants

Terminated Phase 1, PHASE2 Last updated 17 November 2020
What this trial tests

Phase 1, PHASE2 trial testing Positive end-expiratory pressure (PEEP) in Respiratory Insufficiency Syndrome of Newborn in 12 participants. Terminated before completion.

Timeline
11 April 2016
Primary endpoint
8 August 2018
8 August 2018

Quick facts

Lead sponsorChildren's Hospital of Philadelphia
PhasePhase 1, PHASE2
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment12
Start date11 April 2016
Primary completion8 August 2018
Estimated completion8 August 2018
Sites3 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Children's Hospital of Philadelphia

Who can join

Adults 0 Days to 28 Days, any sex, with Respiratory Insufficiency Syndrome of Newborn or Infant, Premature, Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Positive end-expiratory pressure (PEEP) is used in premature infants receiving mechanical ventilation to maintain lungs open and facilitate gas exchange. When ventilation/perfusion mismatch is present, areas of the lung that are open for gas exchange do not match up with areas of the lung that are receiving blood for gas exchange. This study measures the feasibility of enrolling and completing study maneuvers in premature infants for a prospective study measuring the responsiveness of V/Q mismatch to changes in the amount (or level) of PEEP.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Children's Hospital of Philadelphia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03109613.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing